News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bioconsortia Raises $15M Series B Round From Khosla Ventures And Otter Capital



4/7/2014 9:45:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DAVIS, Calif.--(BUSINESS WIRE)--BioConsortia, Inc., an agricultural biotechnology company that uses a proprietary method for the selection of beneficial microbial consortia for crop improvement, has raised an additional $15 million in Series B funding. Khosla Ventures and Otter Capital participated equally in the round. This fund-raising round, along with the recent appointment of Marcus Meadows-Smith as the CEO of BioConsortia, accelerates the company’s plans to commercialize the use of microbial consortia as seed treatments and soil additives.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES